Literature DB >> 7430137

Binding of the eighth component of human complement to the soluble cytolytic complex is mediated by its beta subunit.

J B Monahan, J M Sodetz.   

Abstract

The noncovalently associated alpha-gamma and beta subunits of the eighth component of human complement (C8) were isolated and examined for their ability to recombine to form C8. Each subunit was also examined to determine its capability to interact independently with the C8 binding site on the soluble form of the cytolytic complex of complement. Results indicate that alpha-gamma and beta physically recombine in solution to form native C8 when mixed in equimolar amounts, a finding consistent with the concomitant appearance of C8 hemolytic activity. The ability of each subunit to interact independently with SC5b-7, the precursor of the soluble cytolytic complex which binds C8, was determined by sucrose density gradient analyses. It was found that alpha-gamma exhibits little affinity for SC5b-7, while the beta subunit readily binds to yield a stable complex of SC5b-7(beta). Interaction of beta was specific for the C8 binding site on SC5b-7 as evidenced by the ability to compete with C8. Results indicate that structural domains which mediate specific interaction of C8 with the nascent cytolytic complex are located in the beta subunit of this unusual protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430137

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  DNA polymorphism of the human complement C8 beta gene: formal genetics and intragenic localization.

Authors:  D Herrmann; J M Sodetz; C Rittner; P M Schneider
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.

Authors:  S Schönermark; S Filsinger; B Berger; G M Hänsch
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

3.  Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.

Authors:  J Tschopp; T E Mollnes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

Authors:  G M Hänsch; S Schönermark; D Roelcke
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 8.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system.

Authors:  P Densen; E J Brown; G J O'Neill; F Tedesco; R A Clark; M M Frank; D Webb; J Myers
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

10.  Occurrence of an incomplete C8 molecule in homozygous C8 deficiency in man.

Authors:  J Tschopp; A F Esser; T J Spira; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.